Wong, Samantha
Duan, Lucy
Galper, Alana
Atkinson, Adelle
Upton, Julia
Eiwegger, Thomas http://orcid.org/0000-0002-2914-7829
Funding for this research was provided by:
Food Allergy and Anaphylaxis Program SickKids
Article History
Received: 8 February 2022
Accepted: 30 May 2022
First Online: 16 June 2022
Declarations
:
: The study was approved by the research ethics board at the Hospital for Sick Children (REB#1000071021). Due to the retrospective nature of the study, no consent was obtained. REB approval was obtained prior to the data extraction.
: Not applicable.
: TE reports to act as local PI for company sponsored trials by DBV Therapeutics and sub-investigator for Regeneron and ALK. He holds grants from Innovation Fund Denmark, CIHR outside the submitted work. He is co-Investigator or scientific lead in three investigator initiated oral immunotherapy trials supported by the SickKids Food Allergy and Anaphylaxis Program and serves as associate editor for Allergy. He/his lab received unconditional/kind contributions from Macro Array Diagnostics and ALK Abello. He holds advisory board roles for ALK Abello. and Aimmune. JU reports research support/grants from Novartis, Regeneron, ALK, DBV Therapeutics, CIHR, SickKids Food Allergy and Anaphylaxis Program, and fees from Pfizer, ALK Abello, Bausch Health, Kaleo, Food Allergy Canada, all outside the submitted work. SW, LD, AG and AA have no conflicts of interest to declare.